Low-cost Chinese generic pesticides weigh on the German giant
Countries agree to pause triple-digit duties for 90 days as they talk trade
Projects and firms win investments despite technical, economic, and political challenges
Haya Therapeutics aims to test its lead drug candidate in humans with the new funds
Air Products shifts gears, Chevron Phillips may have a buyer, and Twist spins off a DNA data firm
Synthetic colors like red no. 40 and yellow no. 5 are under pressure from Robert F. Kennedy Jr., states, and consumers alike
Firms adjust supply chains to mitigate costs, but they worry about demand impact
A nylon maker goes bankrupt, a carbon capture start-up raises money, Germany’s Merck acquires SpringWorks, and more
The largest US chemical maker is delaying a Canadian project and planning to idle plants in Europe
Poor economic signals build across the region
Researchers see mixed results trying to replace fluorinated chemicals in refrigeration, textiles, and ion-exchange membranes for fuel cells
Even de-extinction advocates say that Colossal Biosciences’ claims are misleading